SUN PHARMACEUTICAL INDUSTRIES
Back to All Ratios
|
SUN PHARMACEUTICAL INDUSTRIES Last 5 Year Price to Cash Earnings (PCE) History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| PCE(x) | 30.72 | 31.86 | 21.27 | 39.55 | 32.85 |
What is the latest Price to Cash Earnings (PCE) ratio of SUN PHARMACEUTICAL INDUSTRIES ?
| Year | Price to Cash Earnings (PCE) |
|---|---|
| Mar2025 | 30.72 |
| Mar2024 | 31.86 |
| Mar2023 | 21.27 |
| Mar2022 | 39.55 |
| Mar2021 | 32.85 |
How is Price to Cash Earnings (PCE) of SUN PHARMACEUTICAL INDUSTRIES Trending?
| Years | Price to Cash Earnings (PCE) | % Change | |
|---|---|---|---|
| Mar2025 | 30.72 | -3.58 | |
| Mar2024 | 31.86 | 49.79 | |
| Mar2023 | 21.27 | -46.22 | |
| Mar2022 | 39.55 | 20.40 | |
| Mar2021 | 32.85 | - | |
Other Financial Ratios of SUN PHARMACEUTICAL INDUSTRIES
| Operational & Financial Ratios Earnings Per Share CEPS DPS Book NAV/Share Tax Rate | Margin Ratios Core EBITDA Margin EBIT Margin Pre Tax Margin PAT Margin Cash Profit Margin | Performance Ratios ROA ROE ROCE Asset Turnover Sales/Fixed Asset Working Capital/Sales | Efficiency Ratios Fixed Capital/Sales Receivable days Inventory Days Payable days | Valuation Parameters PER Price/Book Yield EV/Net Sales EV/Core EBITDA EV/EBIT EV/CE M Cap / Sales | Growth Ratios Net Sales Growth Core EBITDA Growth EBIT Growth PAT Growth EPS Growth | Financial Stability Ratios Total Debt/Equity Current Ratio Quick Ratio Interest Cover Total Debt/Mcap |
Compare Price to Cash Earnings (PCE) ratio of peers of SUN PHARMACEUTICAL INDUSTRIES
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| SUN PHARMACEUTICAL INDUSTRIES | ₹436,660.6 Cr | 1.4% | -4.5% | 6.5% | Stock Analytics | |
| DIVIS LABORATORIES | ₹176,805.0 Cr | 0.1% | -2.5% | -0.1% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹150,554.0 Cr | -2.7% | 1.2% | 39.3% | Stock Analytics | |
| CIPLA | ₹109,120.0 Cr | -2.3% | -5.3% | -9.8% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹105,920.0 Cr | -0.5% | -4.7% | -5.4% | Stock Analytics | |
| MANKIND PHARMA | ₹97,611.6 Cr | -0.3% | -5.3% | -0.9% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| SUN PHARMACEUTICAL INDUSTRIES | 1.4% |
-4.5% |
6.5% |
| SENSEX | 4.3% |
2.6% |
-6.4% |
You may also like the below Video Courses